oxybutynin has been researched along with Hyperplasia in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Overall, MN patches can offer an effective and safe means of ATRA delivery into the skin, and the ATRA-loaded MN patch appears to be an effective pharmaceutical product providing a novel therapeutic option for seborrheic keratosis." | 2.78 | Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans. ( Asada, H; Hiraishi, Y; Hirobe, S; Iioka, H; Kamiyama, F; Nakagawa, S; Okada, N; Quan, YS, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraishi, Y | 1 |
| Hirobe, S | 1 |
| Iioka, H | 1 |
| Quan, YS | 1 |
| Kamiyama, F | 1 |
| Asada, H | 1 |
| Okada, N | 1 |
| Nakagawa, S | 1 |
1 trial available for oxybutynin and Hyperplasia
| Article | Year |
|---|---|
Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.
Topics: Adult; Animals; Collagen; Cytokines; Dermatologic Agents; Drug Delivery Systems; Female; Heparin-bin | 2013 |